Results 191 to 200 of about 32,124 (226)
Some of the next articles are maybe not open access.

Hydroxymethylated Resorcinol (HMR) and Novolak-Based HMR (n-HMR) Primers to Enhance Bond Durability of Eucalyptus globulus Glulams

Journal of Adhesion Science and Technology, 2009
The effectiveness of the hydroxymethylated resorcinol (HMR) and the novolak-based HMR (n-HMR) primers to enhance bond durability of Eucalyptus globulus glulams was evaluated according to EN 391 (Delamination) and EN 392 (Shear strength) for outdoor load-bearing timber structures (Service Class 3).
Klaus Richter
exaly   +2 more sources

Inhibition of I Ks channels by HMR 1556

Naunyn-Schmiedeberg's Archives of Pharmacology, 2000
Chromanol HMR 1556 [(3R,4S)-(+)-N-[3-hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)chroman-4-yl]-N-methylmethanesulfonamide], a novel inhibitor of the slow component of the delayed outward current in heart muscle cells (IKs), has been characterized in several in-vitro systems.
Andrea Brüggemann
exaly   +3 more sources

Telithromycin (HMR 3647): The first ketolide antibiotic

Drugs of Today, 2001
Telithromycin, the first ketolide antibiotic to undergo clinical development, has been specifically designed to treat community-acquired respiratory tract infections, including those caused by resistant pathogens. Like macrolides, telithromycin inhibits protein synthesis by acting mainly on the 50S ribosomal subunit.
Yan-Qiong, Xiong, Thuan P., Le
openaire   +2 more sources

Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004)

Antimicrobial Agents and Chemotherapy, 1997
HMR 3647 (RU 66647) and HMR 3004 (RU 64004), two ketolides, had MICs at which 50% of the strains are inhibited (MIC50s) of 0.06 to 0.125 microg/ml and MIC90s of 16.0 microg/ml against 352 anaerobes. MIC50s and MIC90s of erythromycin, azithromycin, clarithromycin, and roxithromycin were 0.5 to 2.0 microg/ml and 32.0 to >64.0 microg/ml, respectively ...
L M, Ednie, M R, Jacobs, P C, Appelbaum
openaire   +2 more sources

[Magnetic resonance spectroscopy (HMRS) in migraine].

Przeglad lekarski, 2010
There are 4 million people suffering from migraine in Poland, which account; for 10% of national population. Pathomechanism of migraine is not fully understood. In the recent years multiple studies in migraine patients revealed occurrence of metabolic disorders in nervous system tissue.In 30 subjects with migraine diagnosis magnetic resonance ...
Elzbieta, Trabka-Janik   +4 more
openaire   +2 more sources

HMR-3562. Aventis Pharma.

Current opinion in investigational drugs (London, England : 2000), 2002
Aventis Pharma (formerly Hoechst Marion Roussel) is investigating the ketolides HMR-3562 and HMR-3787 as potential antibacterial agents. The compounds belong to a series of 2-fluoroketolides. They have exhibited potency against a range of gram-positive bacteria and other respiratory tract pathogens including Haemophilus influenzae in vitro and in vivo.
Z, Ma, A S, Florjancic
openaire   +1 more source

In Vitro Activity of HMR 3647 Against Anaerobic Bacteria

Journal of Chemotherapy, 1998
The aim of the present investigation was to determine the in vitro activity of HMR 3647 compared with other antimicrobial agents against anaerobic bacteria. The activity of HMR 3647 was determined against 342 clinical isolates of anaerobic bacteria by the agar dilution method and was compared with azithromycin, clarithromycin, roxithromycin ...
C, Edlund   +3 more
openaire   +2 more sources

Whole-cell metabolism studied with HMR

Chemical & Engineering News Archive, 1979
If the great biochemists Krebs, Embden, and Meyerhof were discovering today the metabolic pathways that bear their names, they might be outfitting their labs with nuclear magnetic resonance instruments. A few labs in the U.S. already are devoting NMR instruments to biochemical problems, instigating what might become a neoclassic era of interest in ...
openaire   +1 more source

HMRS humeral system - evaluation & results

1998
HMRS Humeral System ñ Evaluation ...
CAPANNA, RODOLFO   +6 more
openaire   +2 more sources

HMR-3647

Drugs of the Future, 1998
null Graul, A., null Castaner, J.
openaire   +1 more source

Home - About - Disclaimer - Privacy